Loading company…
Weican Medical develops implantable drug delivery devices for use in veins, arteries, the peritoneal cavity and dialysis access.
Founded in 2023 and based in Nanjing, China, Weican Medical manufactures implantable drug delivery devices, including infusion ports for several clinical applications. In March 2026, it raised venture funding from Kaisheng Southeast Venture Capital, with participation from China Growth Capital and Nuoyu Capital. The funding will support core technology, capacity expansion and market development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in